Back to Soleus Capital Management, L.P.

Soleus Capital Management, L.P.

All holdings · as of Dec 31, 2025

94 positions

CompanyClassValueShares% of portfolio
Tango Therapeutics, Inc.$88.6K10,0000.0%
DELCATH SYSTEMS, INC.$101.0K10,0000.0%
Dyne Therapeutics, Inc.$195.6K10,0000.0%
LB PHARMACEUTICALS INCLBRXCommon Stock$222.6K10,0000.0%
MADRIGAL PHARMACEUTICALS, INC.$291.2K5000.0%
Quoin Pharmaceuticals Ltd.$360.8K25,0000.0%
JASPER THERAPEUTICS INCJSPRCommon Stock$366.0K200,0000.0%
VERACYTE INC$421.0K10,0000.0%
STAAR SURGICAL CO$577.3K25,0000.0%
FRACTYL HEALTH, INC.GUTSCommon Stock$880.0K400,0000.0%
GRAIL, Inc.$941.5K11,0000.0%
Kodiak Sciences Inc.KODCommon Stock$1.68M60,0000.1%
Bicara Therapeutics Inc.$1.68M100,0000.1%
Olema Pharmaceuticals, Inc.$1.75M69,8740.1%
Arcellx, Inc.$1.96M30,0000.1%
Inhibrx Biosciences, Inc.$1.98M25,0000.1%
InspireMD, Inc.NSPRCommon Stock$2.05M1,150,0000.1%
QuidelOrtho Corp$2.14M75,0000.1%
Viking Therapeutics Inc$2.46M70,0000.1%
ZYMEWORKS INC.$2.63M100,0000.1%
Karyopharm Therapeutics Inc.$3.24M440,0000.1%
Tyra Biosciences, Inc.$3.29M125,0000.1%
UROGEN PHARMA LTD$3.51M150,0000.1%
INDIVIOR PLC$3.59M100,0000.2%
Cogent Biosciences, Inc.$4.26M120,0000.2%
Pulmonx Corp$4.50M2,038,3230.2%
CalciMedica, Inc.CALCCommon Stock$4.51M683,9040.2%
Natera, Inc.$4.58M20,0000.2%
NeoGenomics Inc$5.03M427,5040.2%
MoonLake ImmunotherapeuticsMLTXCommon Stock$5.27M400,0000.2%
Oruka Therapeutics, Inc.$5.76M190,0000.2%
ABIVAX SA$6.07M45,0000.3%
Structure Therapeutics Inc.GPCRADR$6.26M90,0000.3%
BELITE BIO, INCBLTEADR$6.46M40,3540.3%
AnaptysBio, Inc.$6.54M135,0000.3%
CG Oncology, Inc.$7.06M170,0000.3%
Evolus, Inc.$7.12M1,070,0000.3%
C4 Therapeutics, Inc.CCCCCommon Stock$7.27M3,803,9420.3%
Avalo Therapeutics, Inc.$8.03M441,9780.3%
Erasca, Inc.ERASCommon Stock$8.04M2,162,1620.3%
CERUS CORP$8.24M4,000,0000.3%
INSMED INC$8.44M48,5000.4%
CIDARA THERAPEUTICS INC$8.57M38,8110.4%
Terns Pharmaceuticals, Inc.$8.59M212,7100.4%
ORTHOPEDIATRICS CORPKIDSCommon Stock$9.33M525,4470.4%
Septerna, Inc.SEPNCommon Stock$10.69M383,3680.5%
Sionna Therapeutics, Inc.$11.05M268,5000.5%
Trevi Therapeutics, Inc.$11.27M900,0000.5%
JADE BIOSCIENCES, INC.$12.29M796,7440.5%
RIGEL PHARMACEUTICALS, INC.$12.85M300,0340.5%
← PrevPage 1 of 2Next →